Itβs maddening that many parents and caretakers are still falling for the #SIDS narrative that didnβt exist before the childhood vax schedule
π’208π35π€¬27π12β€4
FDA fast-tracked RSV shot linked to infant deaths
https://sharylattkisson.com/2024/10/read-fda-fast-tracked-rsv-shot-linked-to-infant-deaths/
#RSVVaccine #SIDS
https://sharylattkisson.com/2024/10/read-fda-fast-tracked-rsv-shot-linked-to-infant-deaths/
#RSVVaccine #SIDS
Sharyl Attkisson
(READ) FDA fast-tracked RSV shot linked to infant deaths | Sharyl Attkisson
Fast-tracked by the US FDA, Beyfortus is linked to higher death rates and severe side effects, including SIDS and thrombosis in infants.
π€¬182π’59β€6π₯2π1π±1
In the summer of 2023, I wrote a two-part substack titled 'The Next Billion Dollar Deal' about the new RSV vaccines.
Read both parts 1 and 2 of my Eye On The Evidence Substack articles on RSV here:
https://drtenpenny.substack.com/p/the-next-billion-dollar-vaccine-deal
https://drtenpenny.substack.com/p/the-next-billion-dollar-vaccine-deal-5f0
As anticipated, the Beyfortus jab from Sanofi and AstraZeneca, fast-tracked by the FDA in July 2023, is now associated with increased mortality risk as well as serious adverse events in infants. Sharyl Attkisson is reporting on it here: https://sharylattkisson.com/2024/10/read-fda-fast-tracked-rsv-shot-linked-to-infant-deaths/
Cases of SIDS (sudden infant death syndrome) have risen, as have adverse events such as heart and nervous system disorders. Respiratory and lung disorders are the most frequently reported adverse event β keep in mind β for a vaccine that is supposed to protect infants against a respiratory virus.
The carnage continues. Despite irrefutable evidence from several credible authorities who reanalyzed the clinical trial data and concluded this jab should NEVER be given to any infant, Beyfortus continues to be in the US childhood immunization schedule, recommended for infants younger than 8 months.
#RSV #RSVVaccines #Vaccines #NotSafeNotEffective #SIDS #EyeOnTheEvidence
Read both parts 1 and 2 of my Eye On The Evidence Substack articles on RSV here:
https://drtenpenny.substack.com/p/the-next-billion-dollar-vaccine-deal
https://drtenpenny.substack.com/p/the-next-billion-dollar-vaccine-deal-5f0
As anticipated, the Beyfortus jab from Sanofi and AstraZeneca, fast-tracked by the FDA in July 2023, is now associated with increased mortality risk as well as serious adverse events in infants. Sharyl Attkisson is reporting on it here: https://sharylattkisson.com/2024/10/read-fda-fast-tracked-rsv-shot-linked-to-infant-deaths/
Cases of SIDS (sudden infant death syndrome) have risen, as have adverse events such as heart and nervous system disorders. Respiratory and lung disorders are the most frequently reported adverse event β keep in mind β for a vaccine that is supposed to protect infants against a respiratory virus.
The carnage continues. Despite irrefutable evidence from several credible authorities who reanalyzed the clinical trial data and concluded this jab should NEVER be given to any infant, Beyfortus continues to be in the US childhood immunization schedule, recommended for infants younger than 8 months.
#RSV #RSVVaccines #Vaccines #NotSafeNotEffective #SIDS #EyeOnTheEvidence
Substack
The Next Billion Dollar Vaccine Deal, Part 1
RSV vaccines for adults
π€¬65β€13π13
TGA hides from questions about sudden infant deaths after vaccination
https://blog.maryannedemasi.com/p/tga-hides-from-questions-about-sudden
#SIDS #childhoodvaccines
https://blog.maryannedemasi.com/p/tga-hides-from-questions-about-sudden
#SIDS #childhoodvaccines
π€¬98π10β€3